HomeASTERDM › Filing
🔔 Get instant alerts when ASTERDM files quarterly results on BSE Start free trial →

Acquisition of Equity Shares of STS Holdings Limited by a Subsidiary of the Company

Filed: 28 Aug 2026, 18:25 IST Exchange: BSE Category: Merger/Acquisition — Equity Acquisition
Acquisition of 14.21% equity shares in STS Holdings Limited by subsidiary Chemistry Intermediate Holdings Limited - Target: STS Holdings Limited, Bangladesh healthcare services company - Turnover: BDT 10,534.24 Million for FY26 - Consideration: USD 44.11 million cash - Price per share: USD equivalent of BDT 273.45 - Acquisition aligns with Merger Framework Agreement dated 29-Nov-2024 - No related party interest; arm's length transaction - Incorporated on 28-Aug-1997; steady turnover growth over 3 years
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 ASTERDM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add ASTERDM to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Aster DM Healthcare Limited

Important. The summary above is generated automatically from Aster DM Healthcare Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.